Cell expansion refers to artificially creating daughter cells from a single cell on a mass scale which aids medical research and curatively as a drug screening tool. The global cell expansion market is estimated to have a CAGR of 18.1% during the forecast period 2016-2023. High government expenditure on cell based research therapies via government research centers and increased investment by the private companies in cell based therapies is expected to inject huge growth during the forecasted period. According to US department of health and services NIH invested $1.459 billion in 2016 into stem cell research projects. The growing aging population in the world is major force that is creating huge growth opportunity in the global cell expansion market. The global rise in chronic diseases and increased funding by government and private firms in research and development and increasing acceptance of stem cell technology is also driving the growth in global cell expansion market. The growing aging population is one of the major driving factors which are injecting huge growth in global cell expansion market. Since the beginning of history being recorded, young children previously were ahead of the number of people aged 65 or more will go down in the coming future. This change is driven by falling fertility rates and remarkable rise in life expectancy, population aging is expected to continue, even accelerate in the next 10 years. The number of people aged 65 or older are anticipated to grow from an estimated 524 million in year 2010 to nearly 1.5 billion in year 2050, with most of the increase in developing countries. According to WHO the world aged population by the end of 2050 is expected to reach 2 billion that is 900 million in 2015. The remarkable improvements in life expectancy over the past century were part of a shift in the leading causes of disease and death. The rising prevalence of chronic life style oriented diseases is also increasing the growth in the global Cell Expansion market. Cancer is the major disease which is increasing with a huge pace, according to WHO, by the end of 2020 there are around 15 million people is projected to suffer from cancer which increases by around 50%.
The high cost of research and development and ethical concerns regarding research on cell biology and stringent regulatory approval process may hamper the growth in the global cell expansion market. The global cell expansion market is having huge opportunities such as huge growth opportunity in the emerging countries, new 3D cell expansion technology and growing aging population and growing potential in emerging economies is expected to contribute a lot in the growth of global cell expansion market.
Source: OBRC Analysis.
The report on global cell expansion market includes type, end-user, application and product.
Type is segmented into:
- Animal Cells
- Human Cells
End-user is segmented into:
- Biopharmaceutical And Biotechnology
- Cell Banks
- Research Institutes
- Others
Application is segmented into:
- Cancer And Cell-Based Research
- Regenerative Medicine And Stem Cell Research
- Others
Product is segmented into:
- Consumables
- Instruments
The revenue for the above application and end-user segments are specific to the cell expansion market. However, the total revenue of these application and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing product and type segment.
The global cell expansion market report has been geographically segmented in:
- North America (U.S. & Canada)
- Asia Pacific (China, India, Japan, RoAPAC)
- Europe (UK, France, Germany, RoE)
- Rest of World
The cell expansion is segmented on the basis of application, cell type, product, end user and geography. The application segment is segmented into cancer and cell-based research, regenerative medicine and stem cell research and others. The end user segment is segmented into biopharmaceutical and biotechnology companies, cell banks, research institutes and others. The cell type segment is segmented into animal cells and human cells. The human cell is sub divided into stem cell and differentiated cell. The stem cell segment is further divided into adult stem cells, embryonic stem cells and induced pluripotent stem cells. The product segment is segmented into consumable and instruments. The consumables segment is further divided into disposables and reagents, media and serum. The instruments segment is sub divided into automated cell expansion systems, bioreactors and cell expansion supporting equipment.
On the basis of geography North America, Europe, Asia Pacific and RoW are the major segments. North America dominates the global cell expansion market; the domination is due to presence of some key players of cell expansion who are investing a huge amount for the development of new technology in the cell expansion which is increasing the North America share in the global cell expansion market. The growth of North American cell expansion market is driven by number of factors such as growing aging population in the region, rising funding from private and government for new technological advancement in stem cell technology and tissue engineering. The rising demonstration of stem cell therapy for the treatment is also driving the growth in the North American cell expansion market. Asia Pacific market is expected to grow with a high CAGR in forecasted period. The demand in the Asia Pacific region is majorly driven by rising demand for stem cell therapies for the treatment due to increasing number of patient population in the region and increasing prevalence of chronic lifestyle diseases.
The major market players of the global cell expansion market are:
- MEDTRONICS’S PLC
- GE HEALTHCARE
- STRYKER CORP.
- THERMO FISHER SCIENTIFIC INC.
- TERUMO BCT INC.
- OTHERS
These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, merger & acquisition is the key strategy adopted by the companies in the cell expansion market.
For Example: In 2015, the Medtronic has announced that they had completed the acquisition of Covidien plc, an Irish-headquartered global health care products company and manufacturer and supplier of medical devices. This acquisition helped Medtronic to enhance the effectiveness of their healthcare product range and also assist the firm to expand their geographical presence.
The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in cell expansion market.
Key reasons to buy the report:
- The report includes market estimation, forecast and analysis for the year 2016-2023
- Report includes detailed analysis of different segments such as type and applications of global cell expansion market.
- Identify and understand the strength, opportunities, challenges and threat of global cell expansion market.
- Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of cell expansion market.
- Detailed analysis of various regulatory policies which affect the global cell expansion market.
How we are different from others:
At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global cell expansion market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the cell expansion market, with giving extensive SCOT analysis of key companies.
Key findings of the global cell expansion market:
- North America held highest revenue share in 2016.
- Human cell segment is expected to account the largest market share due to increasing research investment by private and public organizations.
- Research institute is the major segment of end-users.
- Acquisition is the key strategy adopted by players of cell expansion market.
